Recent years have witnessed significant developments in the field of diabetes treatment, with glp-2 a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as hopeful candidates, showing exceptional results in clinical trials. Retatrutide, a… Read More